Azedra injection – first treatment approved for rare adrenal tumors
The U.S. Food and Drug Administration approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents age 12 and
Anemia
Anemia is a blood disorder characterized by abnormally low levels of healthy red blood cells (RBCs) or reduced hemoglobin (Hgb), the iron-bearing protein in red blood cells that delivers oxygen to tissues throughout the body.
Preventing disparities in colon cancer screening
How to prevent disparities in colon cancer screening – People living in poverty are less likely to be screened regularly for colorectal cancer — and more likely to develop the disease and die from it. How to end these disparities — and raise screening rates, lower disease rates, and prevent deaths?
Vedolizumab an effective treatment for Crohn’s disease and ulcerative colitis
Studies show vedolizumab is an effective treatment for Crohn’s disease and ulcerative colitis – Investigational antibody vedolizumab is an effective treatment for those suffering from ulcerative colitis (UC) and Crohn’s disease (CD) when other treatments have failed, revealed in an international clinical trial.
Darbepoetin alfa does not improve health of anemic heart failure patients
Cleveland Clinic research shows anemia drug does not improve health of anemic heart failure patients — Phase 3 findings published in NEJM provide answers about treatment with darbepoetin alfa – Researchers from Cleveland Clinic and Sweden-based Sahlgrenska University Hospital have found that a commonly used drug to treat anemia in heart failure patients – darbepoetin alfa – does not improve patients’ health, nor does it reduce their risk of death from heart failure.
Anemia drug Omontys recalled due to anaphylaxis
US FDA alerts health care providers of recall of anemia drug Omontys – In US, Omontys Injection is recalled due to reports of anaphylaxis, a serious and life-threatening allergic reaction. Omontys is used to treat anemia in adult dialysis patients. Until further notice, health care providers should stop using Omontys.
Early clamping may interrupt humankind’s first natural stem cell transplant
Do we clamp the umbilical cord too soon? — USF researchers: Early clamping may interrupt humankind’s first ‘natural stem cell transplant’ – The timing of umbilical cord clamping at birth should be delayed just a few minutes longer, suggest researchers at the University of South Florida’s Center of Excellence for Aging and Brain Repair.
Restless legs syndrome appears to occur within families
Restless Legs Syndrome Appears to Occur Within Families – Restless legs syndrome appears to aggregate in families, and the siblings of those who are severely affected appear to have an increased risk of developing the disease, according to a report in the May issue of Archives of Neurology, one of the JAMA/Archives journals.
New safety plan for agents used to treat chemotherapy related anemia
FDA Announces New Safety Plan for Agents Used to Treat Chemotherapy-Related Anemia – The U.S. Food and Drug Administration today approved a risk management program to inform healthcare providers and their patients about the risks of a class of drugs called Erythropoiesis-Stimulating Agents (ESAs).
Measuring and modeling blood flow in malaria
Measuring and modeling blood flow in malaria — Fluid Dynamics Conference in Minneapolis highlights – When people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells.
New iPS therapy pioneered for heart attacks
Induced pluripotent stem cells repair heart, Mayo Clinic study shows — New iPS therapy pioneered for heart attacks. – Induced pluripotent stem (iPS) cells can be used to treat heart disease, revealed by researchers at Mayo Clinic, USA. iPS cells are stem cells converted from adult cells.
Vandetanib with docetaxel improve lung cancer survival
Vandetanib Shows Clinical Benefit When Combined With Docetaxel for Lung Cancer. Combination of targeted agent, chemotherapy improves progression-free survival; therapy inhibits both VEGFR and EGFR. – When combined with standard chemotherapy, an international Phase III trial has shown that the oral targeted therapy vandetanib improves progression-free survival for patients with advanced non-small cell lung cancer, according to research from The University of Texas M. D. Anderson Cancer Center.
Stem cell – gene therapy may cure human genetic diseases
Combined stem cell-gene therapy approach cures human genetic disease in vitro – A study led by researchers at the Salk Institute for Biological Studies, has catapulted the field of regenerative medicine significantly forward, proving in principle that a human genetic disease can be cured using a combination of gene therapy and induced pluripotent stem (iPS) cell technology.